20162017201820192020202120222023Billable/Specific Code
- E32.0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2023 edition of ICD-10-CM E32.0 became effective on October 1, 2022.
- This is the American ICD-10-CM version of E32.0 – other international versions of ICD-10 E32.0 may differ.
ICD-10-CM E32.0 is grouped within Diagnostic Related Group(s):
- 814 Reticuloendothelial and immunity disorders with mcc
- 815 Reticuloendothelial and immunity disorders with cc
- 816 Reticuloendothelial and immunity disorders without cc/mcc
Applicable To
- Hypertrophy of thymus
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to E32.0:
- thymus (gland) (congenital) > Enlargement, enlarged
- involution, thymus (gland) > Failure, failed
- thymus (gland) (persistent) > Hyperplasia, hyperplastic
- thymic, thymus (gland) (congenital) > Hypertrophy, hypertrophic
- thymus (gland) (hyperplasia) > Persistence, persistent (congenital)
